ZA881694B - Adjuvant mixture - Google Patents

Adjuvant mixture

Info

Publication number
ZA881694B
ZA881694B ZA881694A ZA881694A ZA881694B ZA 881694 B ZA881694 B ZA 881694B ZA 881694 A ZA881694 A ZA 881694A ZA 881694 A ZA881694 A ZA 881694A ZA 881694 B ZA881694 B ZA 881694B
Authority
ZA
South Africa
Prior art keywords
adjuvant mixture
adjuvant
mixture
Prior art date
Application number
ZA881694A
Other languages
English (en)
Inventor
Onno Rijke Eric
Original Assignee
Akzo N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo N.V. filed Critical Akzo N.V.
Publication of ZA881694B publication Critical patent/ZA881694B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA881694A 1987-03-17 1988-03-09 Adjuvant mixture ZA881694B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8700629 1987-03-17

Publications (1)

Publication Number Publication Date
ZA881694B true ZA881694B (en) 1988-09-06

Family

ID=19849718

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA881694A ZA881694B (en) 1987-03-17 1988-03-09 Adjuvant mixture

Country Status (9)

Country Link
US (1) US5026543A (forum.php)
EP (1) EP0283085B1 (forum.php)
JP (1) JP2562827B2 (forum.php)
DE (1) DE3875762T2 (forum.php)
DK (1) DK167849B1 (forum.php)
ES (1) ES2052685T3 (forum.php)
GR (1) GR3007039T3 (forum.php)
HU (1) HU202119B (forum.php)
ZA (1) ZA881694B (forum.php)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL105325A (en) * 1992-04-16 1996-11-14 Minnesota Mining & Mfg Immunogen/vaccine adjuvant composition
CN1120310A (zh) * 1993-03-11 1996-04-10 塞科雷泰克公司 在粘膜表面转运免疫原的聚合粘膜粘合剂
AU5543294A (en) * 1993-10-29 1995-05-22 Pharmos Corp. Submicron emulsions as vaccine adjuvants
US5961970A (en) * 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
GB9417742D0 (en) * 1994-09-03 1994-10-19 Univ Nottingham Macrophage stimulating composition
BE1008977A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
US5891393A (en) * 1996-04-09 1999-04-06 The University Of North Carolina At Chapel Hill Method for the microbial decontamination of blood platelets
GB9622159D0 (en) * 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
US6572874B1 (en) 1998-05-15 2003-06-03 Umd, Inc. Vaginal delivery of bisphosphonates
US6197327B1 (en) * 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
US6416779B1 (en) 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
FR2775601B1 (fr) * 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves
FR2776928B1 (fr) * 1998-04-03 2000-06-23 Merial Sas Vaccins adn adjuves
ES2311451T3 (es) * 1999-03-24 2009-02-16 The Secretary Of State For Defence Carbohidratos policationicos como immuestimulantes en vacunas.
US6943152B1 (en) * 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
MY129765A (en) 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
US7018638B2 (en) 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
US6676958B2 (en) 2001-06-19 2004-01-13 Advanced Bioadjuvants, Llc Adjuvant composition for mucosal and injection delivered vaccines
EP1594524B1 (en) 2003-01-21 2012-08-15 Novartis Vaccines and Diagnostics, Inc. Use of tryptanthrin compounds for immune potentiation
EP1608369B1 (en) 2003-03-28 2013-06-26 Novartis Vaccines and Diagnostics, Inc. Use of organic compounds for immunopotentiation
EP2277595A3 (en) 2004-06-24 2011-09-28 Novartis Vaccines and Diagnostics, Inc. Compounds for immunopotentiation
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
EP1973406B1 (en) 2005-12-28 2014-03-12 Advanced Bionutrition Corporation A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form
DK2371383T3 (en) 2005-12-29 2015-11-30 Boehringer Ingelheim Vetmed Use of a PCV2 immunogenic composition for reduction of clinical symptoms in pigs
DK3320919T3 (da) 2005-12-29 2020-08-03 Boehringer Ingelheim Animal Health Usa Inc Multivalente pcv2-immunogeniske sammensætninger og fremgangsmåder til at fremstille sådanne sammensætninger
ES2376492T3 (es) * 2006-03-23 2012-03-14 Novartis Ag Compuestos de imidazoquinoxalina como inmunomoduladores.
EP2010530A2 (en) * 2006-03-23 2009-01-07 Novartis AG Methods for the preparation of imidazole-containing compounds
WO2007109812A2 (en) * 2006-03-23 2007-09-27 Novartis Ag Immunopotentiating compounds
US20100129397A1 (en) 2006-12-11 2010-05-27 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) * 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
US20080292663A1 (en) * 2007-05-22 2008-11-27 Gerber Jay D Adjuvant compositions and methods for delivering vaccines
WO2009126356A2 (en) 2008-01-23 2009-10-15 Boehringer Ingelheim Vetmedica, Inc. Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
MX2011006152A (es) 2008-12-09 2011-07-28 Gilead Sciences Inc Moduladores de receptores tipo toll.
WO2010114169A1 (en) * 2009-03-31 2010-10-07 Japan As Represented By The Director-General Of National Institute Of Infectious Diseases Method for prophylaxis of influenza using vaccine for intranasal administration
DK2435554T3 (en) 2009-05-26 2017-10-30 Advanced Bionutrition Corp STABLE DRY POWDER COMPOSITION WITH BIOLOGICALLY ACTIVE MICRO-ORGANISMS AND / OR BIOACTIVE MATERIALS AND PROCEDURES FOR ITS PREPARATION
WO2011094469A2 (en) 2010-01-28 2011-08-04 Advanced Bionutrition Corporation Dry glassy composition comprising a bioactive material
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
WO2013138334A1 (en) 2012-03-12 2013-09-19 Advanced Bioadjuvants, Llc Adjuvant and vaccine compositions
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
EP3052516B1 (en) 2013-10-02 2020-01-01 Boehringer Ingelheim Animal Health USA Inc. Pcv2 orf2 protein variant and virus like particles composed thereof
WO2016001907A1 (en) 2014-07-02 2016-01-07 Prendergast Patrick T Mogroside iv and mogroside v as agonist/stimulator/un-blocking agent for toll-like receptor 4 and adjuvant for use in human/animal vaccine and to stimulate immunity against disease agents.
ES2881809T3 (es) 2015-07-29 2021-11-30 Advanced Bionutrition Corp Composiciones probióticas secas estables para usos dietéticos especiales
JP7339285B2 (ja) 2018-06-04 2023-09-05 アプロス セラピューティクス， インコーポレイテッド Ｔｌｒ７ペプチドコンジュゲート
JP7728560B2 (ja) 2018-07-02 2025-08-25 アユヴィス リサーチ インク． 新規免疫調節小分子

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178350A (en) * 1961-05-15 1965-04-13 Cutler Lab Inc Biologic antigens adjuvanted with a colloidally water-soluble polymer of acrylic acidcrosslinked with polyallyl sucrose or polyallyl pentaerythritol
US3919411A (en) * 1972-01-31 1975-11-11 Bayvet Corp Injectable adjuvant and compositions including such adjuvant
US3869546A (en) * 1972-12-22 1975-03-04 Cutter Lab Adjuvant compositions and medicinal mixtures comprising them
DE3308458A1 (de) * 1983-03-10 1984-09-13 Behringwerke Ag, 3550 Marburg Verfahren zur adjuvierung von vaccinen
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
US4772466A (en) * 1983-08-22 1988-09-20 Syntex (U.S.A.) Inc. Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4606918A (en) * 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants

Also Published As

Publication number Publication date
DE3875762D1 (de) 1992-12-17
US5026543A (en) 1991-06-25
DK167849B1 (da) 1993-12-27
JP2562827B2 (ja) 1996-12-11
DK141488A (da) 1988-09-18
EP0283085B1 (en) 1992-11-11
EP0283085A1 (en) 1988-09-21
HU202119B (en) 1991-02-28
HUT47224A (en) 1989-02-28
DK141488D0 (da) 1988-03-15
ES2052685T3 (es) 1994-07-16
DE3875762T2 (de) 1993-05-13
JPS63253032A (ja) 1988-10-20
GR3007039T3 (forum.php) 1993-07-30

Similar Documents

Publication Publication Date Title
ZA881694B (en) Adjuvant mixture
ZA884209B (en) Novel compounds
GB8729614D0 (en) Novel compounds
GB8729802D0 (en) Novel compounds
GB8730051D0 (en) Novel compounds
GB8730052D0 (en) Novel compounds
GB8814083D0 (en) Polysocyanate mixture
ZA882145B (en) Novel compounds
ZA886536B (en) Novel compounds
GB8727987D0 (en) Novel compounds
CS374087A1 (en) Lapping mixture
CS759387A1 (en) Preparation mixtures
HU206925B (en) Caustics base mixture
BG46341A1 (en) Form mixture
IE871404L (en) 3-hydroxy-3-phenylbutan-2-one preparation
GB8709601D0 (en) Herbicidal mixture
GB8729215D0 (en) Novel compounds
IE870827L (en) Novel compounds
GB8729806D0 (en) Novel compounds
GB8729805D0 (en) Novel compounds
GB8729803D0 (en) Novel compounds
GB8729612D0 (en) Novel compounds
GB8729390D0 (en) Novel compounds
GB8729364D0 (en) Novel compounds
GB8729808D0 (en) Novel compounds